|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/18 | |||
| A61K 9/19 | |||
| A61K 47/42 | |||
| A61K 47/26 | |||
| A61K 47/02 | |||
| C07K 16/22 |
| (11) | Patento numeris | 2968460 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14721569.3 |
| Europos patento paraiškos padavimo data | 2014-03-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/021792 |
| Data | 2014-03-07 |
| (87) | Numeris | WO 2014/164301 |
| Data | 2014-10-09 |
| (30) | Numeris | Data | Šalis |
| 201361775974 P | 2013-03-11 | US |
| (72) |
PARK, Sungae, US
KUHNS, Scott, US
RATTAN, Jennifer, US
PHILLIPS, Joseph, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | PROTEIN FORMULATIONS |
| PROTEIN FORMULATIONS |